• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Aerobic-resistance training and high-intensity interval training may improve metabolic and functional outcomes in adults with type 2 diabetes

bySiwen LiuandSimon Pan
January 13, 2026
in Chronic Disease, Endocrinology
Reading Time: 3 mins read
Pediatric DKA associated with recent acute care visits
Share on FacebookShare on Twitter

1. 12 weeks of aerobic–resistance training and high-intensity interval training improved metabolic, functional, and quality-of-life outcomes in adults with type 2 diabetes mellitus compared with standard care.

2. HIIT was superior for fasting glucose reduction and muscle mass gains, while aerobic–resistance training produced greater improvements in HbA1c, fat reduction, and quality of life.

Evidence Rating Level: 1 (Excellent)

Aerobic exercise training, resistance exercise training, and high-intensity interval training (HIIT) each provide unique physiological benefits for the management of type 2 diabetes mellitus (T2DM). However, direct comparison between aerobic–resistance training (A + R) and high-intensity interval training (HIIT) in T2DM management is lacking. This study thus compared the effects of A + R and HIIT on clinical outcomes in adults with T2DM, relative to standard care. This randomised controlled trial included participants aged 30–65 years with T2DM who were recruited from a hospital in Ajman, United Arab Emirates, between 2 June 2021 and 30 November 2022. Participants were randomised 1:1:1 to either the combined aerobic and resistance exercise training (A + R) group, HIIT training group, or control group (usual care without structured exercise). Both A+R and HIIT programs were delivered 3–5 times weekly for 12 weeks. All 90 participants randomised completed the intervention and follow-up, with 30 participants in each group (A+R group: mean [SD] age = 55.1 [6.2] years, HIIT group: mean [SD] age = 45.9 [10.3] years, control group: mean [SD] age = 50.4 [8.5] years). Compared to the control group at 12-weeks, both the HIIT and A+R group showed greater reduction in fasting glucose (HIIT: Mean Difference [MD] −29.1 mg/dL; 95% CI −41.2 to −17.0; A+R: MD −20.6 mg/dL; 95% CI −31.0 to −10.2), HbA1c (HIIT: MD −3.35%; 95% CI −4.11 to −2.5; A+R: MD −3.33%; 95% CI −4.03 to −2.62), and fasting insulin (HIIT: MD −7.16 mIU/L; 95% CI −10.04 to −4.28; A+R MD −8.87 mIU/L; 95% CI −11.77 to −5.97). Compared to the control group, the Homeostatic Model Assessment of Insulin Resistance improved in the A+R group (MD −2.33; 95% CI −3.63 to −1.03) but not in the HIIT group. Functional capacity (6-minute walk distance) also increased in both the HIIT group (MD +178.9 m; 95% CI 130.5 to 227.4) and A+R group (MD +233.6 m; 95% CI 191.8 to 275.5) compared to the control. Additionally, in both HIIT and A+R groups, fat-free mass increased (HIIT MD +7.54 kg; 95% CI 4.71 to 10.36; A+R MD +5.96 kg; 95% CI 3.06 to 8.86) while subcutaneous fat (HIIT: MD −7.16%; 95% CI −9.33 to −4.99; A+R: MD −8.37%; 95% CI −10.65 to −6.09) and visceral fat (HIIT: MD −4.70%; 95% CI −5.93 to −3.47; A+R: MD −4.58%; 95% CI −5.86 to −3.31) were reduced. Finally, quality of life improved across domains in both groups (e.g., physical domain: HIIT MD +10.29; 95% CI 4.06 to 16.51; A+R MD +13.77; 95% CI 6.62 to 20.91) compared to the control group. Overall, this study found that aerobic–resistance training (A + R) and high-intensity interval training (HIIT) improved metabolic, functional, and quality-of-life outcomes in adults with type 2 diabetes mellitus compared with standard care. HIIT was superior for fasting glucose reduction and muscle mass gains, while A + R produced greater improvements in HbA1c, fat reduction, and quality of life. These findings support tailoring exercise interventions to therapeutic goals. Future longitudinal studies are needed to confirm these findings.

Click here to read this study in PLOS One

Image: PD

RELATED REPORTS

Higher coffee intake is associated with lower visceral fat despite similar body mass index

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Dietary habits are associated with dementia risk in patients with Alzheimer’s pathology

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aerobic exerciseendocrinologyglucose controlHIITlifestyletype 2 diabetes
Previous Post

An elevated Apolipoprotein B to Apolipoprotein A ratio may be associated with increased kidney stone recurrence

Next Post

Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery

RelatedReports

Chronic Disease

Higher coffee intake is associated with lower visceral fat despite similar body mass index

September 8, 2026
Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Chronic Disease

Dietary habits are associated with dementia risk in patients with Alzheimer’s pathology

July 3, 2026
Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Chronic Disease

Resistance training is associated with lower risk of type 2 diabetes

July 2, 2026
Next Post
Prenatal antidepressant exposure may increase risk of poor motor development

Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery

Abusive head trauma results in fewer productive life-years

Brain-penetrant enzyme replacement therapy improves biomarkers in mucopolysaccharidosis type II

USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea

Nuzolvence (Zoliflodacin) first oral Gonorrhea treatment shows non-inferior cure rates

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.